Zobrazeno 1 - 10
of 161
pro vyhledávání: '"Michael G. Alexandrakis"'
Autor:
Vassia Renieri, D. Liapi, Eugene Daphnis, Aikaterini Sfiridaki, Athanasios Alegakis, Kostas Stylianou, Aikaterini Livadiotaki, Michael G. Alexandrakis, Ioanna Manika
Publikováno v:
Acta haematologica. 144(2)
Background: The inherited thrombophilic mutations of the factor V gene (FVG1691A Leiden-FVL), prothrombin gene (PTG20210A), and the methylenetetrahydrofolate reductase gene C677T (MTHFR C677T) are risk factors for thromboembolic events and are relate
Autor:
Maria Tzardi, Constantina A. Pappa, Rodanthi Vyzoukaki, Michael G. Alexandrakis, Maria Kokonozaki, George Tsirakis, Nikolaos Androulakis
Publikováno v:
Clinical Therapeutics. 38:297-301
Purpose The aim of the study is to estimate whether bone marrow mast cell density (MCD) in multiple myeloma (MM) correlates with circulating levels of various angiogenic factors. Methods In 70 patients with newly diagnosed active MM, we measured MCD
Autor:
Maria Devetzoglou, Anastasia Papadopoulou, Constantina A. Pappa, George Tsirakis, Michael G. Alexandrakis, Samer Masud, Rodanthi Vyzoukaki, Andreas N. Antonakis
Publikováno v:
British Journal of Medicine and Medical Research. 15:1-10
Aims: There is increased mast cell density (MCD) in multiple myeloma (MM) bone marrow (BM) that is correlated with advanced disease stage. Mast cells (MCs) produce various mediators promoting MM growth and bone metabolism. The aim of this study was t
Autor:
Constantine A Pappa, Athanasios Alegakis, Anna Boula, Styliani Sarantoulaki, Peggy Kanellou, Maria Kokonozaki, Michael G. Alexandrakis, Rodanthi Vyzoukaki, Stavroula Kyriakaki, Emilia Stavroulaki
Publikováno v:
Critical reviews in oncogenesis. 22(3-4)
The FLT3-ligand is a molecule implicated in hematopoiesis. The aim of the present study was to detect any possible connections between serum levels of FLT3-L and multiple myeloma (MM) proliferation markers, such as serum levels of interleukin-6 (IL-6
Autor:
Anastasia Papadopoulou, Constantina A. Pappa, Maria Devetzoglou, Athina Xekalou, Nikolaos Androulakis, Rodanthi Vyzoukaki, Athanasios Alegakis, Maria Kokonozaki, Michael G. Alexandrakis
Publikováno v:
Tumor Biology. 36:8491-8497
Multiple myeloma (MM) is a plasma cell neoplasm characterized by bone marrow infiltration from malignant plasma cells. Mast cells play an important role in inflammation and angiogenesis in malignant diseases. The aim of the study was to evaluate the
Autor:
Anna Boula, George Tsirakis, Constantina A. Pappa, Ioannis K. Neonakis, Nektaria Goulidaki, F. E. Psarakis, Michael G. Alexandrakis
Publikováno v:
Pathology & Oncology Research. 21:929-934
In multiple myeloma the angiogenic process is enhanced by various mediators. Among them interleukin-10 (IL-10), secreted mainly by myeloma-associated macrophages seems to participate in myeloma progression with variable manners. The aim of the study
Autor:
Harini G. Acharya, Maria Tzardi, Yasuyuki Negishi, Constantina A. Pappa, Quoc Thai Dinh, Hans Jürgen Hoffmann, Carlos Senent, George Tsirakis, Gabriela Canto, Ralph Mösges, Michael G. Alexandrakis, Maria Devetzoglou, María José Torres, Rosario Gonzalez-Mendiola, Robert Bals, Nieves Cabañes, Ayako Wakabayashi, Masumi Shimizu, Anatoli Astvatsatourov, Rodanthi Vyzoukaki, Juliane Nguyen, Adriana Ariza, Per Stahl-Skov, Ricardo Palacios, Cristobalina Mayorga, Claas Gloistein, Yohko Nakagawa, Kimihiro Okubo, Silke Allekotte, Francisca Arribas, Babu Gonipeta, Venu Gangur, Druckerei Stückle, Sebastian Heck, Satz Mengensatzproduktion, Galicia Davila, Fernando Pineda, Natalia Blanca-López, Duc Dung Le, Takachika Hiroi, Jose Julio Laguna, Hidemi Takahashi, Sitaram Parvataneni, Miguel Blanca, Ryosuke Murakami
Publikováno v:
International Archives of Allergy and Immunology. 168:I-IV
Autor:
Constantina A. Pappa, Maria Devetzoglou, George Tsirakis, Rodanthi Vyzoukaki, Maria Tzardi, Michael G. Alexandrakis
Publikováno v:
International Archives of Allergy and Immunology. 168:263-268
Background: Osteolytic bone disease is a major hallmark in multiple myeloma (MM) progression and affects many patients. Several inflammatory cells are involved in MM progression. Among them, mast cells (MCs) accumulated in the bone marrow (BM) microe
Publikováno v:
Current Angiogenesis. 2:76-95
Autor:
Constantina A. Pappa, Anna Boula, E. Stavroulaki, George Tsirakis, V Bantouna, A. Kolovou, F. E. Psarakis, Michael G. Alexandrakis
Publikováno v:
Hematological Oncology. 31:201-205
Angiogenesis is an essential process for the expansion of multiple myeloma (MM), in which many angiogenic factors participate. Endoglin (CD105) is a transforming growth factor-β co-receptor, being mainly expressed in angiogenic endothelial cells and